Genetic polymorphism and neuroanatomical changes in schizophrenia.

Area of Science:

• Neurogenetics
• Psychiatric Genetics

Background:

• Schizophrenia is a complex mental disorder with a significant genetic component.
• Understanding the genetic spectrum is crucial for identifying risk factors and developing targeted therapies.

Approach:

• This review synthesizes findings from recent meta-analyses on schizophrenia-associated genes.
• It examines the roles of disrupted-in-schizophrenia 1 (DISC1), catechol-O-methyltransferase (COMT), monoamine oxidases-A/B (MAO-A/B), glutamic acid decarboxylase 67 (GAD67), and neuregulin 1 (NRG1).

Key Points:

• DISC1 polymorphism is linked to increased schizophrenia risk and prefrontal cortex connectivity issues.
• NRG1 gene variations affect brain structure, including the corpus callosum and white matter tracts.
• COMT and MAO-A genes influence dopaminergic systems and inflammation, while GAD67 deficits impact GABAergic neurotransmission and neuronal maturation.

Conclusions:

• Specific gene polymorphisms significantly elevate schizophrenia risk.
• These genetic factors are implicated in neurodevelopmental alterations and neurotransmitter system dysfunctions.
• Further research into these genetic pathways can inform diagnostic and therapeutic strategies for schizophrenia.